Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12431439 | 0.78 | TSHR (0.38) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL561587 | 0.77 | MAPT (0.39) | PTGS1AKR1C3CYP2C9MAPTALDH1A1 | |
| SCHEMBL15563291 | 0.76 | TSHR (0.37) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL15563292 | 0.76 | TSHR (0.37) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL12572454 | 0.75 | CYP2C9 (0.32) | PTGS1AKR1C3CYP2C9MAPT | |
| SCHEMBL2866038 | 0.75 | MAPK1 (0.35) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL1535989 | 0.72 | MAPK1 (0.34) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL1535991 | 0.72 | MAPK1 (0.34) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL13725734 | 0.72 | TSHR (0.38) | TSHRNPC1MAPK1RAB9AHSD17B10 | |
| SCHEMBL13725736 | 0.72 | TSHR (0.38) | TSHRNPC1MAPK1RAB9AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129787-B2 | Cosmetic compositions containing oxazoline functionalized polymers and polyamine compounds | L'OREAL (FR) | 2021-09-28 | — | — | US | disclosed |
| US-9884004-B2 | Compositions and methods for treating hair | L'OREAL (FR) | 2018-02-06 | — | — | US | disclosed |
| US-9884002-B2 | Compositions and methods for treating hair | L'OREAL (FR) | 2018-02-06 | — | — | US | disclosed |
| US-9884003-B2 | Compositions and methods for treating hair | L'OREAL (FR) | 2018-02-06 | — | — | US | disclosed |
| US-9814668-B2 | Hair styling compositions comprising latex polymers | L'OREAL (FR) | 2017-11-14 | — | — | US | disclosed |
| US-9814669-B2 | Hair cosmetic composition containing latex polymers and a silicone-organic polymer compound | L'OREAL (FR) | 2017-11-14 | — | — | US | disclosed |
| US-9795556-B2 | Compositions and methods for treating hair | L'OREAL (FR) | 2017-10-24 | — | — | US | disclosed |
| US-20160175237-A1 | HAIR COSMETIC COMPOSITION CONTAINING LATEX POLYMERS AND A SILICONE-ORGANIC POLYMER COMPOUND | L'OREAL (FR) | 2016-06-23 | — | — | US | disclosed |
| US-20150004117-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
| US-20150004115-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
| US-20150004116-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
| US-20150004118-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150004116-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | SUCLG1, NACA, DPM1 | TSHR 3323/4885NPC1 4621/4885PTGS1 1285/4885 |
| US-20160175237-A1 | HAIR COSMETIC COMPOSITION CONTAINING LATEX POLYMERS AND A SILICONE-ORGANIC POLYMER COMPOUND | SUCLG1, NACA, EPM2A | TSHR 2270/4885NPC1 3559/4885PTGS1 3413/4885 |
| US-11129787-B2 | Cosmetic compositions containing oxazoline functionalized polymers and polyamine compounds | SRM, KRT18, ODC1 | TSHR 4075/4885NPC1 4498/4885PTGS1 3993/4885 |
| US-20150004117-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | SUCLG1, DPM1, NACA | TSHR 4108/4885NPC1 4554/4885PTGS1 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.